Cargando...
Comparative effectiveness and safety of empagliflozin on cardiovascular mortality and morbidity in adults with type 2 diabetes
BACKGROUND: Based on a single placebo-controlled randomized clinical trial, empagliflozin is licensed to reduce cardiovascular death in diabetes and comorbid cardiovascular disease. METHODS: We examined the comparative effectiveness of empagliflozin on mortality and cardiovascular morbidity in type...
Gardado en:
| Publicado en: | Ann Transl Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AME Publishing Company
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5733315/ https://ncbi.nlm.nih.gov/pubmed/29285488 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.08.43 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|